- Report
- February 2024
- 120 Pages
Global
From €4207EUR$4,750USD£3,647GBP
- Report
- February 2024
- 115 Pages
Global
From €4207EUR$4,750USD£3,647GBP
- Report
- February 2024
- 118 Pages
Global
From €4207EUR$4,750USD£3,647GBP
- Report
- February 2024
- 111 Pages
Global
From €4207EUR$4,750USD£3,647GBP
- Report
- April 2023
- 120 Pages
Global
From €4207EUR$4,750USD£3,647GBP
- Report
- April 2023
- 115 Pages
Global
From €4207EUR$4,750USD£3,647GBP
- Report
- April 2023
- 125 Pages
Global
From €4207EUR$4,750USD£3,647GBP
- Report
- April 2023
- 110 Pages
Global
From €4207EUR$4,750USD£3,647GBP
- Report
- April 2023
- 117 Pages
Global
From €4207EUR$4,750USD£3,647GBP
- Report
- April 2023
- 120 Pages
Global
From €4207EUR$4,750USD£3,647GBP
- Report
- April 2023
- 126 Pages
Global
From €4207EUR$4,750USD£3,647GBP
- Report
- August 2022
- 111 Pages
Global
From €4207EUR$4,750USD£3,647GBP
- Report
- August 2022
- 112 Pages
Global
From €4207EUR$4,750USD£3,647GBP
- Report
- August 2022
- 118 Pages
Global
From €4207EUR$4,750USD£3,647GBP
- Report
- April 2024
- 123 Pages
Global
From €2799EUR$3,160USD£2,426GBP
€3498EUR$3,950USD£3,033GBP
- Report
- December 2023
- 147 Pages
Global
From €3153EUR$3,560USD£2,733GBP
€3941EUR$4,450USD£3,417GBP
- Report
- December 2023
- 145 Pages
Global
From €3153EUR$3,560USD£2,733GBP
€3941EUR$4,450USD£3,417GBP
- Report
- December 2023
- 144 Pages
Global
From €3153EUR$3,560USD£2,733GBP
€3941EUR$4,450USD£3,417GBP
- Report
- September 2023
- 141 Pages
Global
From €3153EUR$3,560USD£2,733GBP
€3941EUR$4,450USD£3,417GBP
- Report
- March 2022
- 100 Pages
Global
From €3153EUR$3,560USD£2,733GBP
€3941EUR$4,450USD£3,417GBP

The Contract Research Organization (CRO) market within the biotechnology sector is a rapidly growing industry. It provides services to biotechnology companies, such as drug discovery, preclinical and clinical trials, and regulatory affairs. CROs are often used to outsource research and development activities, allowing biotechnology companies to focus on their core competencies. CROs also provide access to specialized expertise and resources, such as specialized laboratory equipment and personnel.
CROs are increasingly being used to reduce costs and speed up the development process. They are also used to reduce the risk associated with drug development, as they can provide access to a wide range of expertise and resources.
Some of the major companies in the CRO market include Parexel, Quintiles, Charles River Laboratories, Covance, and PRA Health Sciences. Show Less Read more